Clinical Trial Update: Daratumumab for Familial Cerebral Cavernous Malformations: A Single-Arm Safety and Efficacy Study [EARLY_Phase 1]

View source ↗

Summary

This clinical trial update concerns an early-phase, single-arm study evaluating the safety and efficacy of daratumumab for cerebral cavernous malformation (fami…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cerebral Cavernous Malformation

Drugs mentioned

• Daratumumab (daratumumab)

Snippet

Sponsor: Beijing Tiantan Hospital | Conditions: Cavernous Malformation, Cerebral | EARLY_Phase 1 | Status: NOT_YET_RECRUITING